ORIX Corporation

NYSE:IX

Financial - Credit Services

Financial Services
$33.11 +1.14%

+$0.45 today

Market cap
$36.76B
Beta
0.73
P/E (TTM)
15.7
EPS (TTM)
$412.82
Dividend yield
2.42%
52W Low $21.14High $40.50

Volume 0.30M

Average 0.36M

IX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

ORIX CorporationNYSE: IX

Research & Development · Q1 FY2027 · quarter ended Jun 2026

Research & development remains negative

Q1 FY2027 research & development was ¥0, compared with ¥0 a year earlier. Trailing-twelve-month research & development was ¥0.

Context

  • Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near ¥0 or moves back toward the trailing-twelve-month quarterly average of ¥0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
¥0— QoQ
Last fiscal yearMar 2026
¥0— YoY
LTMJun 2026
¥0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

JPY · from the income statement

Latest · FY2026
0 JPY
Year-over-year change
—

Research & Development vs competitors

How IX compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for IX, versus a peer median of 0.0%.
IX Competitors
Research & Development for IX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOFISoFi Technologies, Inc.LTM Jun 2026$378.95M USD——6.8%
IXORIX CorporationLTM Jun 2026¥0 JPY——0.0%
SYFSynchrony FinancialLTM Sep 2026$0 USD——0.0%
FCFSFirstCash Holdings, IncLTM Sep 2026$0 USD——0.0%
PRGPROG Holdings, Inc.LTM Mar 2026$0 USD——0.0%
NAVINavient CorporationLTM Mar 2026$0 USD——0.0%
Peer median (excluding IX) ———0.0%

Competitors are the stored peer set for IX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

JPY
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue2.51T2.66T2.81T2.87T3.53T
Cost of Revenue1.57T1.62T1.64T1.67T2.4T
Gross Profit940.79B1.04T1.17T1.2T1.13T
Gross Margin37.5%39.1%41.7%41.8%32.1%
Research & Development00000
Selling, General & Admin522.78B555.97B627.63B646.05B0
Operating Expenses647.9B704.59B813.33B868.72B361.57B
Depreciation & Amortization320.34B340.25B364.24B399.53B404.79B
EBITDA743.78B813.04B916.36B944.67B1.34T
EBITDA Margin29.7%30.5%32.6%32.9%38.0%
Operating Income292.88B335.92B360.71B331.83B770.68B
Operating Margin11.7%12.6%12.8%11.5%21.8%
Interest Income281.7B319.48B348B0387.62B
Interest Expense68.23B127.62B188.33B169.05B205.58B
Other Income / Expenses216.56B56.26B109.26B148.64B(37.55B)
Income Before Tax509.45B392.18B469.98B480.46B733.13B
Pre-Tax Margin20.3%14.7%16.7%16.7%20.8%
Income Tax Expense186.59B95.25B131.39B128.83B247.16B
Net Income317.38B290.34B346.13B351.63B475.04B
Net Margin12.7%10.9%12.3%12.2%13.5%
EPS (Basic)259.37231.35298.55307.74425.01
EPS (Diluted)259.07231.04298.05307.16423.42
Weighted Avg Shares1.2B1.18B1.16B1.14B1.12B
Weighted Avg Shares (Diluted)1.2B1.18B1.16B1.14B1.12B

ORIX Corporation

NYSE:IX

Intrinsic Alpha fair value

Locked

Current Price

$33.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.